STONERIDGE INVESTMENT PARTNERS LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 92 filers reported holding CYTOKINETICS INC in Q4 2013. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
STONERIDGE INVESTMENT PARTNERS LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2016$149,000
+35.5%
15,6550.0%0.02%
+37.5%
Q1 2016$110,000
-51.3%
15,655
-27.5%
0.02%
-46.7%
Q4 2015$226,000
-61.6%
21,586
-75.4%
0.03%
-63.4%
Q3 2015$588,000
-1.8%
87,926
-1.4%
0.08%
+10.8%
Q2 2015$599,000
+39.6%
89,176
+40.9%
0.07%
+48.0%
Q1 2015$429,000
-12.8%
63,307
+3.1%
0.05%
-23.1%
Q4 2014$492,000
+191.1%
61,386
+27.5%
0.06%
+160.0%
Q3 2014$169,000
-26.5%
48,1410.0%0.02%
-26.5%
Q2 2014$230,000
-30.7%
48,141
+37.6%
0.03%
-46.9%
Q1 2014$332,000
+42.5%
34,974
-2.2%
0.06%
+42.2%
Q4 2013$233,00035,7740.04%
Other shareholders
CYTOKINETICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$41,198,0004.18%
Virtus ETF Advisers LLC 93,309$672,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 105,324$758,0000.55%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$19,065,0000.20%
WASATCH ADVISORS LP 1,761,882$12,686,0000.16%
PINNACLE ASSOCIATES LTD 888,415$6,397,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 84,690$610,0000.08%
Birchview Capital, LP 10,000$72,0000.05%
Piermont Capital Management Inc. 16,530$119,0000.04%
Tekla Capital Management LLC 137,797$992,0000.04%
View complete list of CYTOKINETICS INC shareholders